Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00890500
Recruitment Status : Completed
First Posted : April 29, 2009
Last Update Posted : October 8, 2013
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Fate Therapeutics